Risk Factors and Prescription Pattern among Patients with Congestive Heart Failure

IF 0.4 Q4 PHARMACOLOGY & PHARMACY Journal of Pharmacology & Pharmacotherapeutics Pub Date : 2021-04-01 DOI:10.4103/jpp.jpp_25_21
Jison Jose, B. Baby, Shabeer Ahammed, Sharad Chand, U. Nandakumar, B. Vinay, K. Subramanyam, J. Joel
{"title":"Risk Factors and Prescription Pattern among Patients with Congestive Heart Failure","authors":"Jison Jose, B. Baby, Shabeer Ahammed, Sharad Chand, U. Nandakumar, B. Vinay, K. Subramanyam, J. Joel","doi":"10.4103/jpp.jpp_25_21","DOIUrl":null,"url":null,"abstract":"Congestive heart failure (CHF) is considered a condition that impairs the ventricle’s ability to fill or eject blood due to a structural or functional disorder of the heart, having a prevalence rate of 0.3%–2%.[1,2] Left-sided heart failure is most commonly caused by ischemic heart disease and hypertension (HTN), whereas right-sided heart failure is generally caused by the later stage of left-sided heart failure. These cardiac conditions may lead to mental complications, including stress and depression.[3] In India, there is less data regarding the exact prevalence and incidence of CHF.[4] Availability of these data may lead to the planning of safe and effective therapy. Drug utilization studies help in identifying the trends of the therapy for the disease.[5,6] A prescription pattern study provides an insight into the treatment compliance with hospital formulary and other guidelines.[7] Deviation and irrationality in the standard therapy will help in amending the prescribing guidelines in the hospital.[8] The clinical pharmacist plays an essential role in assessing the risk factors and drug prescription patterns.[9] Hence, this study is carried out to identify the risk factors associated with CHF and pharmacotherapy in patients diagnosed with CHF.","PeriodicalId":16761,"journal":{"name":"Journal of Pharmacology & Pharmacotherapeutics","volume":"12 1","pages":"94 - 96"},"PeriodicalIF":0.4000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacology & Pharmacotherapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpp.jpp_25_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Congestive heart failure (CHF) is considered a condition that impairs the ventricle’s ability to fill or eject blood due to a structural or functional disorder of the heart, having a prevalence rate of 0.3%–2%.[1,2] Left-sided heart failure is most commonly caused by ischemic heart disease and hypertension (HTN), whereas right-sided heart failure is generally caused by the later stage of left-sided heart failure. These cardiac conditions may lead to mental complications, including stress and depression.[3] In India, there is less data regarding the exact prevalence and incidence of CHF.[4] Availability of these data may lead to the planning of safe and effective therapy. Drug utilization studies help in identifying the trends of the therapy for the disease.[5,6] A prescription pattern study provides an insight into the treatment compliance with hospital formulary and other guidelines.[7] Deviation and irrationality in the standard therapy will help in amending the prescribing guidelines in the hospital.[8] The clinical pharmacist plays an essential role in assessing the risk factors and drug prescription patterns.[9] Hence, this study is carried out to identify the risk factors associated with CHF and pharmacotherapy in patients diagnosed with CHF.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
充血性心力衰竭患者的危险因素及处方模式
充血性心力衰竭(CHF)被认为是一种由于心脏结构或功能紊乱而损害心室充注或排出血液能力的疾病,患病率为0.3%-2%。[1,2]左侧心力衰竭最常见由缺血性心脏病和高血压(HTN)引起,而右侧心力衰竭通常由左侧心力衰竭的后期引起。这些心脏病可能会导致精神并发症,包括压力和抑郁。[3] 在印度,关于CHF的确切患病率和发病率的数据较少。[4] 这些数据的可用性可能有助于制定安全有效的治疗计划。药物利用研究有助于确定该疾病的治疗趋势。[5,6]处方模式研究提供了对医院处方集和其他指南的治疗依从性的深入了解。[7] 规范治疗的偏差和不合理将有助于修改医院的处方指南。[8] 临床药剂师在评估危险因素和药物处方模式方面发挥着重要作用。[9] 因此,本研究旨在确定与CHF相关的危险因素以及诊断为CHF的患者的药物治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
37
期刊最新文献
Allelic Variants in the Warfarin-related Genes VKORC1 and CYP2C9 in a Western Saudi Population N-Acetyl-l-Cysteine Ameliorations RenalFunction Early After Renal Ischemia and Reperfusion; it is not Protective over a LongTerm under a High-Sodium Diet in Rats Rationalization of Antibiotic Prescription: Modulation of the Gut Microbiome and Possibilities of Minimizing the Risks for the Development of Antibiotic Resistance—A Narrative Review The Science of Antioxidants: Balancing thePros and Cons for Our Health Use of Fixed-dose Combination Therapy with Remogliflozin and Vildagliptin as an Add-on Drug in Improving the Glycemic Control of Type 2 Diabetes Mellitus: An Observational Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1